{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Colon", "Herbal medicine", "Inflammation", "KIOM-MA-128", "Tight junction", "Ulcerative colitis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28679372", "DateCompleted": {"Year": "2017", "Month": "08", "Day": "18"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "07", "Day": "05"}], "Language": ["eng"], "ELocationID": ["354", "10.1186/s12906-017-1855-4"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "17", "Issue": "1", "PubDate": {"Year": "2017", "Month": "Jul", "Day": "05"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Fermented herbal formula KIOM-MA-128 protects against acute colitis induced by dextran sodium sulfate in mice.", "Pagination": {"StartPage": "354", "MedlinePgn": "354"}, "Abstract": {"AbstractText": ["Colitis is a well-known subtype of inflammatory bowel disease and is caused by diverse factors. Previous research has shown that KIOM-MA elicits anti-inflammatory and anti-allergic effects on various diseases. KIOM-MA-128, our novel herbal formula, was generated from KIOM-MA using probiotics to improve the therapeutic efficacy. We investigated whether KIOM-MA-128 has protective activity in a mouse model of acute colitis induced by dextran sodium sulfate (DSS).", "Colitis was induced by DSS administered to ICR mice in drinking water. KIOM-MA-128 (125 or 250\u00a0mg/kg) was orally administered once per day. The body weights of the mice were measured daily, and colonic endoscopies were performed at 5 and 8\u00a0days. Colon length as well as histological and cytokine changes were observed at the end of drug administration.", "KIOM-MA-128 has pharmacological activity in an acute colitis model. KIOM-MA-128 reduced the loss of body weight and disease activity index (DAI) and inhibited the abnormally short colon lengths and the colonic damage in this mouse model of acute colitis. Moreover, KIOM-MA-128 suppressed pro-inflammatory cytokine expression and maintained the integrity of the tight junctions during DSS-induced colitis.", "The results indicated that KIOM-MA-128 protects against DSS-induced colitis in mice and suggested that this formula might be a candidate treatment for inflammatory bowel disease (IBD)."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Medicine (KM)-Application Center, Korea Institute of Oriental Medicine, 70 Cheomdan-ro, Dong-gu, Daegu, 41062, Republic of Korea."}], "LastName": "Kim", "ForeName": "Dong-Gun", "Initials": "DG"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Medicine (KM)-Application Center, Korea Institute of Oriental Medicine, 70 Cheomdan-ro, Dong-gu, Daegu, 41062, Republic of Korea."}], "LastName": "Lee", "ForeName": "Mi-Ra", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Medicine (KM)-Application Center, Korea Institute of Oriental Medicine, 70 Cheomdan-ro, Dong-gu, Daegu, 41062, Republic of Korea."}], "LastName": "Yoo", "ForeName": "Jae-Myung", "Initials": "JM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Medicine (KM)-Application Center, Korea Institute of Oriental Medicine, 70 Cheomdan-ro, Dong-gu, Daegu, 41062, Republic of Korea. kipark@kiom.re.kr."}], "LastName": "Park", "ForeName": "Kwang-Il", "Initials": "KI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Korea Medicine (KM)-Application Center, Korea Institute of Oriental Medicine, 70 Cheomdan-ro, Dong-gu, Daegu, 41062, Republic of Korea. jyma@kiom.re.kr."}], "LastName": "Ma", "ForeName": "Jin-Yeul", "Initials": "JY"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfates"}, {"RegistryNumber": "0YPR65R21J", "NameOfSubstance": "sodium sulfate"}, {"RegistryNumber": "9042-14-2", "NameOfSubstance": "Dextran Sulfate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["chemically induced", "drug therapy", "genetics", "immunology"], "DescriptorName": "Colitis"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Colon"}, {"QualifierName": ["genetics", "immunology"], "DescriptorName": "Cytokines"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Dextran Sulfate"}, {"QualifierName": [], "DescriptorName": "Drug Compounding"}, {"QualifierName": [], "DescriptorName": "Fermentation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": ["metabolism"], "DescriptorName": "Lacticaseibacillus rhamnosus"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": ["administration & dosage", "metabolism"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry", "microbiology"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Sulfates"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tight Junctions"}], "CoiStatement": "ETHICS APPROVAL AND CONSENT TO PARTICIPATE: All procedures were approved by the Korea Institute of Oriental Medicine Institutional Animal Care and Use Committee (KIOM-IACUC) and were conducted in accordance with the US guidelines (NIH publication #83\u201323, revised in 1985). CONSENT FOR PUBLICATION: Not applicable. COMPETING INTERESTS: The authors declare no conflicts of interest. PUBLISHER\u2019S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573):1641\u20131657. doi: 10.1016/S0140-6736(07)60751-X.", "ArticleIdList": ["10.1016/S0140-6736(07)60751-X", "17499606"]}, {"Citation": "Wang G, Ren J, Liu S, Chen J, Gu G, Wang X, Fan C, Li J. Clinical characteristics of non-perianal fistulating Crohn's disease in China: a single-center experience of 184 cases. Chin Med J. 2012;125(14):2405\u20132410.", "ArticleIdList": ["22882911"]}, {"Citation": "Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12(5):S3\u2013S9. doi: 10.1097/01.MIB.0000195385.19268.68.", "ArticleIdList": ["10.1097/01.MIB.0000195385.19268.68", "16378007"]}, {"Citation": "Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3(7):521\u2013533. doi: 10.1038/nri1132.", "ArticleIdList": ["10.1038/nri1132", "12876555"]}, {"Citation": "Langmead L, Rampton D. Review article: complementary and alternative therapies for inflammatory bowel disease. Aliment Pharmacol Ther. 2006;23(3):341\u2013349. doi: 10.1111/j.1365-2036.2006.02761.x.", "ArticleIdList": ["10.1111/j.1365-2036.2006.02761.x", "16422993"]}, {"Citation": "Oh Y-C, Cho W-K, Jeong YH, Im GY, Kim A, Hwang Y-H, Kim T, Song KH, Ma JY. Evidence-Based Complementary and Alternative Medicine. 2012. A Novel Herbal Medicine KIOM-MA Exerts an Anti-Inflammatory Effect in LPS-Stimulated RAW 264.7 Macrophage Cells; p. 2012.", "ArticleIdList": ["PMC3518860", "23243447"]}, {"Citation": "Chung TH, Kang TJ, Cho W-K, Im GY, Lee GS, Yang MC, Cho C-W, Ma JY. Evidence-Based Complementary and Alternative Medicine 2012. 2012. Effectiveness of the novel herbal medicine, KIOM-MA, and its bioconversion product, KIOM-MA128, on the treatment of atopic dermatitis.", "ArticleIdList": ["PMC3290922", "22454683"]}, {"Citation": "Kim A, Im M, Yim N-H, Hwang Y-H, Yang HJ, Ma JY. The novel herbal cocktail MA128 suppresses tumor growth and the metastatic potential of highly malignant tumor cells. Oncol Rep. 2015;34(2):900\u2013912.", "ArticleIdList": ["26035620"]}, {"Citation": "Park KI, Kim DG, Yoo JM, Ma JY. The Herbal Medicine KIOM-MA128 Inhibits the Antigen/IgE-Mediated Allergic Response in Vitro and in Vivo. Molecules. 2016;21(8):1015. doi: 10.3390/molecules21081015.", "ArticleIdList": ["10.3390/molecules21081015", "PMC6273402", "27527133"]}, {"Citation": "Park KI, Kim DG, Lee BH, Ma JY. Fermented Herbal Formulas KIOM-MA128 Ameliorate IL-6-Induced Intestinal Barrier Dysfunction in Colon Cancer Cell Line. Mediat Inflamm. 2016;2016:13.", "ArticleIdList": ["PMC5131250", "27980357"]}, {"Citation": "Kim A, Ma JY. Anti-melanogenic activity of the novel herbal medicine, MA128, through inhibition of tyrosinase activity mediated by the p38 mitogen-activated protein kinases and protein kinase signaling pathway in B16F10 cells. Pharmacogn Mag. 2014;10(39):463. doi: 10.4103/0973-1296.139774.", "ArticleIdList": ["10.4103/0973-1296.139774", "PMC4189259", "25298661"]}, {"Citation": "Tanaka K-I, Namba T, Arai Y, Fujimoto M, Adachi H, Sobue G, Takeuchi K, Nakai A, Mizushima T. Genetic evidence for a protective role for heat shock factor 1 and heat shock protein 70 against colitis. J Biol Chem. 2007;282(32):23240\u201323252. doi: 10.1074/jbc.M704081200.", "ArticleIdList": ["10.1074/jbc.M704081200", "17556362"]}, {"Citation": "Daperno M, Sostegni R, Lavagna A, Crocella L, Ercole E, Rigazio C, Rocca R, Pera A. The role of endoscopy in inflammatory bowel disease. Eur Rev Med Pharmacol Sci. 2004;8(5):209.", "ArticleIdList": ["15638232"]}, {"Citation": "Becker C, Fantini M, Wirtz S, Nikolaev A, Kiesslich R, Lehr H, Galle P, Neurath M. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut. 2005;54(7):950\u2013954. doi: 10.1136/gut.2004.061283.", "ArticleIdList": ["10.1136/gut.2004.061283", "PMC1774595", "15951540"]}, {"Citation": "Mizoguchi A. Animal models of inflammatory bowel disease. Prog Mol Biol Transl Sci. 2011;105:263\u2013320. doi: 10.1016/B978-0-12-394596-9.00009-3.", "ArticleIdList": ["10.1016/B978-0-12-394596-9.00009-3", "22137435"]}, {"Citation": "Colitis\u2013Pathophysiology U: Inflammatory bowel disease part I: ulcerative colitis\u2013pathophysiology and conventional and alternative treatment options. Alternative medicine review 2003, 8(3):247\u2013283.", "ArticleIdList": ["12946238"]}, {"Citation": "Chassaing B, Aitken JD, Malleshappa M, Vijay-Kumar M. Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice. Curr Protoc Immunol 2014:15.25. 11-15.25. 14.", "ArticleIdList": ["PMC3980572", "24510619"]}, {"Citation": "Wirtz S, Neufert C, Weigmann B, Neurath MF. Chemically induced mouse models of intestinal inflammation. Nat Protoc. 2007;2(3):541\u2013546. doi: 10.1038/nprot.2007.41.", "ArticleIdList": ["10.1038/nprot.2007.41", "17406617"]}, {"Citation": "McKnight AJ, Macfarlane AJ, Dri P, Turley L, Willis AC, Gordon S. Molecular cloning of F4/80, a murine macrophage-restricted cell surface glycoprotein with homology to the G-protein-linked transmembrane 7 hormone receptor family. J Biol Chem. 1996;271(1):486\u2013489. doi: 10.1074/jbc.271.1.486.", "ArticleIdList": ["10.1074/jbc.271.1.486", "8550607"]}, {"Citation": "Reinecker H, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott R, Raedler A. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1993;94(1):174. doi: 10.1111/j.1365-2249.1993.tb05997.x.", "ArticleIdList": ["10.1111/j.1365-2249.1993.tb05997.x", "PMC1534387", "8403503"]}, {"Citation": "Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol. 2009;124(1):3\u201320. doi: 10.1016/j.jaci.2009.05.038.", "ArticleIdList": ["10.1016/j.jaci.2009.05.038", "PMC4266989", "19560575"]}, {"Citation": "Poritz L, Lynch C, Tilberg A, Khin S, Page M, Koltun W. Decreased expression of occludin in the intestine of patients with inflammatory bowel disease. In: FASEB JOURNAL: 1997: FEDERATION AMER SOC EXP BIOL 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA; 1997: 1800-1800."}, {"Citation": "Kucharzik T, Walsh SV, Chen J, Parkos CA, Nusrat A. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins. Am J Pathol. 2001;159(6):2001\u20139.", "ArticleIdList": ["PMC1850599", "11733350"]}, {"Citation": "Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA. Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol. 1986;103(3):755\u2013766. doi: 10.1083/jcb.103.3.755.", "ArticleIdList": ["10.1083/jcb.103.3.755", "PMC2114282", "3528172"]}, {"Citation": "Poritz LS, Garver KI, Green C, Fitzpatrick L, Ruggiero F, Koltun WA. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res. 2007;140(1):12\u201319. doi: 10.1016/j.jss.2006.07.050.", "ArticleIdList": ["10.1016/j.jss.2006.07.050", "17418867"]}]}], "History": [{"Year": "2016", "Month": "12", "Day": "13"}, {"Year": "2017", "Month": "6", "Day": "22"}, {"Year": "2017", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "8", "Day": "19", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "7", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["28679372", "PMC5499052", "10.1186/s12906-017-1855-4", "10.1186/s12906-017-1855-4"]}}]}